Founded in 2013, Doylestown-based N-Zyme Scientifics develops and supplies research enzymes for glycomics and proteomics, with a particular focus on MALDI mass spectrometry spatial glycan imaging. Its original PNGase F PRIME™ remains the company’s most popular product, while the team’s enzyme formulations have been optimized for tissue, serum and other biomedical research applications. The company was co-founded by business and scientific specialists, including glycoproteomics pioneer Anand Mehta and mass spectrometry imaging researcher Richard Drake.